Earth Science Tech, Inc. (OTC: ETST) released its financial and operational results for the third fiscal quarter ended Dec. 31, 2025, showcasing significant growth in revenue and profitability. The company reported revenue of $8.4 million, a 14.1% increase year over year, driven by continued momentum across its operating subsidiaries. Gross profit reached $6.4 million, representing a robust 76.3% margin, underscoring the company's ability to maintain high profitability despite scaling operations.
Net income for the quarter totaled $910,000, up an impressive 341% from the prior-year period, while adjusted EBITDA came in at $1.2 million. These results highlight the effectiveness of Earth Science Tech's strategic initiatives, which include optimizing its portfolio of businesses in compounding pharmaceuticals, telemedicine, and real estate development. The company's total assets increased to $8.1 million, and it ended the quarter with $416,000 in cash, $773,000 in working capital, and no bank debt, reflecting a solid balance sheet.
During the first nine months of fiscal 2026, Earth Science Tech repurchased and retired 3.7 million shares, signaling management's confidence in the company's valuation and commitment to enhancing shareholder value. The company's operating leverage is evident as it continues to expand its footprint heading into calendar 2026. For more details on the financial results, investors can refer to the full press release at https://ibn.fm/emIBm.
Earth Science Tech operates as a strategic holding company focused on value creation through acquisitions and operational optimization. Its wholly owned subsidiaries include RxCompoundStore.com, LLC, Peaks Curative, LLC, Avenvi, LLC, Mister Meds, LLC, Earth Science Foundation, Inc., Las Villas Health Care, Inc., and DOConsultations, LLC, along with an 80% interest in MagneChef. The company's diversified business model positions it to capitalize on growth opportunities in the healthcare and real estate sectors.
The strong quarterly performance comes as Earth Science Tech continues to execute its growth strategy, leveraging its subsidiaries to drive revenue and profitability. With no bank debt and improving cash flows, the company is well-positioned to pursue further expansion initiatives. Investors and stakeholders can find the latest updates on ETST in the company's newsroom at https://ibn.fm/ETST.
